|
End-of-day quote
Other stock markets
|
||
| - EGP | - |
|
| 05-21 | The Arab Drug Company Reports Earnings Results for the Nine Months Ended March 31, 2026 | CI |
| 04-30 | Arab Drug Company 9-month net profit EGP 196.4 million | RE |
| Market Cap | 2.73B 54.66M 47.66M 44.14M 41.32M 77.49M 5.16B 77.96M 524M 203M 2.54B 205M 201M 8.81B | P/E 2024 |
5.46x | P/E 2025 | 6.08x |
|---|---|---|---|---|---|
| Enterprise Value | 3.16B 63.33M 55.22M 51.14M 47.88M 89.79M 5.98B 90.33M 607M 235M 2.94B 238M 233M 10.21B | EV / Sales 2024 |
0.98x | EV / Sales 2025 | 1.47x |
| Free-Float |
19.57% | Yield 2024 |
10.4% | Yield 2025 | 4.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tariq Ali
DFI | Director of Finance/CFO | - | - |
Yosef Omr Amer
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | 2021-09-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.21% | -3.04% | +44.03% | +143.07% | 980B | |
| -2.48% | -5.18% | +52.47% | +39.15% | 550B | |
| -2.14% | -4.94% | +16.83% | +57.08% | 382B | |
| +0.25% | -3.09% | +23.33% | +16.04% | 316B | |
| +0.61% | -1.69% | +27.35% | +13.73% | 272B | |
| +0.22% | -3.10% | +24.67% | +30.49% | 268B | |
| +4.59% | +1.98% | -38.43% | -46.26% | 199B | |
| -1.19% | -4.95% | +16.68% | +47.69% | 182B | |
| -1.35% | -1.46% | +14.06% | +59.26% | 154B | |
| Average | -0.30% | -3.02% | +20.11% | +40.03% | 366.93B | |
| Weighted average by Cap. | -0.78% | -3.68% | +29.49% | +63.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 786M 15.73M 13.72M 12.71M 11.89M 22.31M 1.48B 22.44M 151M 58.42M 731M 59.06M 57.8M 2.54B | 1.12B 22.4M 19.53M 18.09M 16.93M 31.75M 2.11B 31.95M 215M 83.16M 1.04B 84.08M 82.27M 3.61B |
| Net income | 103M 2.06M 1.8M 1.66M 1.56M 2.92M 194M 2.94M 19.73M 7.65M 95.66M 7.73M 7.57M 332M | 228M 4.56M 3.98M 3.69M 3.45M 6.47M 431M 6.51M 43.72M 16.95M 212M 17.13M 16.77M 736M |
| Net Debt | 284M 5.7M 4.97M 4.6M 4.31M 8.08M 537M 8.12M 54.57M 21.15M 265M 21.38M 20.92M 919M | 433M 8.67M 7.56M 7M 6.55M 12.29M 818M 12.37M 83.07M 32.19M 403M 32.55M 31.85M 1.4B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
